Global Experimental Animal Model Market Growth 2023-2029

Global Experimental Animal Model Market Growth 2023-2029

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

LPI (LP Information)' newest research report, the “Experimental Animal Model Industry Forecast” looks at past sales and reviews total world Experimental Animal Model sales in 2022, providing a comprehensive analysis by region and market sector of projected Experimental Animal Model sales for 2023 through 2029. With Experimental Animal Model sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Experimental Animal Model industry.

This Insight Report provides a comprehensive analysis of the global Experimental Animal Model landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Experimental Animal Model portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Experimental Animal Model market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Experimental Animal Model and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Experimental Animal Model.

The global Experimental Animal Model market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Experimental Animal Model is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Experimental Animal Model is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Experimental Animal Model is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Experimental Animal Model players cover Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Experimental Animal Model market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Mouse
Rabbit
Monkey
Zebrafish
Others

Segmentation by application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Experimental Animal Model market?

What factors are driving Experimental Animal Model market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Experimental Animal Model market opportunities vary by end market size?

How does Experimental Animal Model break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.